Archive for the ‘Biotech Holdings Ltd. BIOHF’ Category

Stock Guru Featured Client: Biotech Holdings Ltd. (BIOHF.OB)

Thursday, April 3rd, 2008

Biotech Holdings Ltd. (BIOHF.OB) is a pharmaceutical production and distribution company. BIOHF is known for its development of a new anti-diabetic medication known as Sucanaon™ and Diab II™. The company is focused on distributing and marketing its developed medication and intends to develop combination therapies with its trademarked medication to help improve treatment of Type II diabetes.

Biotech’s anti-diabetic medication, Sucanon™, is approved by regulatory authorities in Mexico and has proven effective in clinical trials. The medication acts to increase the body’s ability to use insulin, in turn causing decreased levels of blood sugar for Type II diabetes sufferers. There are only three drugs approved in the world for insulin treatments, and Sucanon™ is one of these drugs. Sucanon™ can be found in Costco Mexico and Wal-Mart Mexico. The product is also available to Type II diabetics in North America through the Internet.

Biotech Holdings, Inc. is based in Vancouver, Canada but does its tableting and packaging in Mexico City. Mexico is the eighth largest pharmaceutical market and has one of the largest diabetic markets in the world. The company has received regulatory approval in Peru, and has a signed agreement for distribution in Ecuador and Costa Rica.

Let us hear your thoughts: Biotech Holdings Ltd. Message Board

Biotech Holdings Ltd. (BIOHF.OB) (TSXV: BIO) Heading South of the Border for More Profits

Friday, July 6th, 2007

Biotech Holdings Ltd. (OTCBB: BIOHF) (TSXV: BIO) is heading south of the border with the announcement that it is expanding distribution of its Sucanon diabetes drug in Mexico and other markets.BIOHF took over Sucanon distribution from an appointed marketing company in September, 2006 and currently distributes through more than ten chains. Retail chains distributing Sucanon include big-box retailer Wal-Mart and drugstore chains Farmacias Benavides and Farmacias del Ahorro.

Catalog and call-center sales to better-off customers are conducted principally through Internacional de Productos. Overall, the distribution system that has been created allows Sucanon to be offered to Type II diabetics through approximately 2,000 retail outlets.

BIOHF is also working to improve the availability of Sucanon to poorer sectors of the Mexican population, who cannot afford to buy regularly at normal retail prices. Earlier this month, the company participated by invitation at a “Diabetes and Society National Meeting” organized by the Mexican Social Security Institute (Instituto Mexicano del Seguro Social or IMSS) to find channels and methods by which government support for purchasing of Sucanon can be extended among the less well-off. The IMSS is a government institution which is involved in providing medical care for approximately 48 million people.

BIOHF recently signed a distribution agreement covering four markets in Latin America and is continuing to pursue distribution discussions in a number of Latin American markets including Brazil and Argentina as well as in some markets outside Latin America.

BIOHF is a pharmaceutical production and distribution company based in Vancouver, Canada. The company has developed an important new anti-diabetic medication, which has been trademarked as “Sucanon” and “Diab II.” The company is now focused on the distribution and marketing of this medication. BIOHF also looks forward to development of combination therapies using this new proprietary medication in combination with other well-established treatments for Type II Diabetes, which is one of the world’s most widespread and rapidly growing diseases.

BIOHF Heading South of the Border for More Profits

Thursday, July 5th, 2007

Biotech Holdings Ltd. (OTCBB: BIOHF) (TSXV: BIO) is heading south of the border with the announcement that it is expanding distribution of its Sucanon diabetes drug in Mexico and other markets.

BIOHF took over Sucanon distribution from an appointed marketing company in September, 2006 and currently distributes through more than ten chains. Retail chains distributing Sucanon include big-box retailer Wal-Mart and drugstore chains Farmacias Benavides and Farmacias del Ahorro.

Catalog and call-center sales to better-off customers are conducted principally through Internacional de Productos. Overall, the distribution system that has been created allows Sucanon to be offered to Type II diabetics through approximately 2,000 retail outlets.

BIOHF is also working to improve the availability of Sucanon to poorer sectors of the Mexican population, who cannot afford to buy regularly at normal retail prices. Earlier this month, the company participated by invitation at a “Diabetes and Society National Meeting” organized by the Mexican Social Security Institute (Instituto Mexicano del Seguro Social or IMSS) to find channels and methods by which government support for purchasing of Sucanon can be extended among the less well-off. The IMSS is a government institution which is involved in providing medical care for approximately 48 million people.

BIOHF recently signed a distribution agreement covering four markets in Latin America and is continuing to pursue distribution discussions in a number of Latin American markets including Brazil and Argentina as well as in some markets outside Latin America.

BIOHF is a pharmaceutical production and distribution company based in Vancouver, Canada. The company has developed an important new anti-diabetic medication, which has been trademarked as “Sucanon” and “Diab II.” The company is now focused on the distribution and marketing of this medication. BIOHF also looks forward to development of combination therapies using this new proprietary medication in combination with other well-established treatments for Type II Diabetes, which is one of the world’s most widespread and rapidly growing diseases.